Global credit card fraud worth Rs 100 cr busted in Bengaluru

Mandya, Jun 13: Degree colleges will begin classes after the lockdown is lifted and dates for examinations will be announced later, said deputy chief minister CR Ashwath Narayan on Friday.

Speaking at College of Agriculture, Mandya (VC Farm) on Friday, Ashwath Narayan said the lockdown will be completely phased out on June 30 and degree colleges will begin classes after that. “We will speak with all stakeholders to chalk out measures as to how to reopen degree colleges amidst coronavirus scare. All students must continue their studies and be prepared for exams,” he said.

Narayan said the cabinet has approved to upgrade VC Farm as a university and an ordinance will soon be promulgated in this regard. “There is a need to change the present curriculum to meet present day requirements. VC Farm will be made into a world class agriculture university and a vice chancellor will be appointed,” he said.

“Apart from traditional education, we must concentrate on skill-based education as it should create more job opportunities. We are committed to establish more skill-based educational institutes in Mandya district,” Narayan said.

Later Narayan visited Shivaragudda near Maddur and inspected 48 acres of government land which could be used for establishing skill-based education institutions. “This land was earlier used for imparting skill-based education in a collaboration with Denmark. Sir M Visvesvaraya had established skill-based institutions here in 1923 and now they have become defunct. The then prime minister of Denmark had inaugurated this century old institution. We will revive it and this will help local youths,” he said.

‘Ticket promised only to R Shankar’

When asked, Narayan said R Shankar, who quit the Congress-JD(S) coalition and joined BJP will be given a party ticket to contest the legislative council election. “Except Shankar, the high command did not promise council tickets to those who quit congress and JD(S) and joined our party. It is true that there is hectic lobbying in BJP to get tickets,” he said.

Udupi, Jul 18: Noted multi-lingual scholar Dr Uliyar Padmanabha Upadhyaya passed away last night at a private hospital in Manipal. The 88-year-old was survived by a son and a daughter.

His wife Susheela Uadhyaya, who was also a multi-lingual scholar, had passed away in January 2014 at the age of 77. The duo had compiled the six-volume Tulu Lexicon. Its first volume was published in 1988 and the last volume in 1997.

Son of Sitaram Upadhyaya, who was a scholar in the court of the Raja of Travancore, Dr Padmanabha was born on April 10, 1932 at Uliyar in Majur Village near Kaup in Udupi district. 

The Upadhyaya couple had conducted serious research work in linguistics and folk culture and produced a number of books-some of them jointly, some individually and some in collaboration with others. 

Dr Padmanabha had acquired three Master of Arts degrees in Sanskrit, Kannada and Linguistics from Madras, Kerala and Pune Universities, Vidwan in Hindi and PhD in Linguistics from the Pune University for his thesis titled “A Comparative Study of Kannada Dialects”.

He was a visiting Professor at the Universities of London and Paris. He knew Hindi, Kannada, Tulu, Malayalam, Tamil, English, French and Olof, the language of Senegal in Africa.

His works include Nanjanagudu Kannada (Vokkaliga Dialect), Coorg Kannada, Kuruba - A Dravidian Language, Kannada - A Phonetic Language, Malayalam Language and Literature (with Ms. Susheela), Effect of Bilingualism on Bidar Kannada, Coimbatore Tamil, Kannada as Spoken by Different Population Groups in Mysore City, Dravidian and Negro African: Ethno Linguistic Study (with Ms. Susheela), Conversational Kannada, Coastal Karnataka and Bhuta Worship: Aspects of a Ritualistic Theatre (with Ms. Susheela).

Also Read: Eminent linguist Dr Susheela P Upadhyaya no more

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.